Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

02/06/2021 Parc de l’Alba in a WHO publication on the redevelopment of contaminated sites 27/04/2021 Natura Bissé: when architecture reflects the brand identity 08/04/2021 ASTIP, the future hub for advanced research in the Barcelona Synchrotron Park 25/03/2021 4th anniversary of the setting up of Stradivarius headquarter in the Barcelona Synchrotron Park 05/03/2021 T-Systems, a leading IT service provider with a Data Centre in the Barcelona Synchrotron Park 18/02/2021 SENER participates in the Perseverance rover which is landing on Mars today
1 2 3 4 5 6 7